These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3396495)

  • 1. Pharmacokinetics of cefotaxime in elderly patients.
    Sugihara H; Yoneyama K; Sorimachi H; Kamo T; Imamura S; Akashi N; Yamada M; Shimizu T
    Drugs; 1988; 35 Suppl 2():93-6. PubMed ID: 3396495
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of cefotaxime and desacetylcefotaxime in elderly patients.
    Ludwig E; Székely E; Csiba A; Graber H
    Drugs; 1988; 35 Suppl 2():51-6. PubMed ID: 3396489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patients.
    Urien S; Laurent N; Barre J; Druguet M; Bouvier D'yvoire M; Maire P
    Eur J Clin Pharmacol; 2004 Mar; 60(1):11-6. PubMed ID: 14767629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on transfer of cefotaxime into bone tissue.
    Makiyama T; Asai T
    Drugs; 1988; 35 Suppl 2():88-92. PubMed ID: 3396494
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of fever on cefotaxime pharmacokinetics].
    Demotes-Mainard F; Albin H; Ragnaud JM; Gin H; Vincon G; Aubertin J
    Pathol Biol (Paris); 1988 Feb; 36(2):155-8. PubMed ID: 3279384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with lower doses of cefotaxime in hospitalized patients with serious infections.
    Shah A; Madhavan T; Drelichman V; Price J
    J Chemother; 1989 Jul; 1(4 Suppl):650-1. PubMed ID: 16312575
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of cefotaxime in cirrhotic patients with or without ascites].
    Vincent P; Colombel JF; Husson MO; Izard D; Paris JC; Leclerc H
    Presse Med; 1988 Dec; 17(44):2331-4. PubMed ID: 2974968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefotaxime and desacetylcefotaxime in renal failure patients undergoing continuous arteriovenous haemofiltration.
    Hasegawa H; Takahashi K; Imada A; Horiuchi A
    Drugs; 1988; 35 Suppl 2():78-81. PubMed ID: 3396493
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition kinetics and dosage regimen of cefotaxime in cross-bred male calves.
    Sharma SK; Srivastava AK; Bal MS
    Vet Res; 1995; 26(3):168-73. PubMed ID: 7795667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Dtsch Tierarztl Wochenschr; 1990 Aug; 97(8):324-7. PubMed ID: 2209455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
    Moukhtar I; Nawishy S; Sabbour M
    Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous infusion with intermittent bolus administration of cefotaxime on blood and cavity fluid drug concentrations in neonatal foals.
    Hewson J; Johnson R; Arroyo LG; Diaz-Mendez A; Ruiz-López JA; Gu Y; del Castillo JR
    J Vet Pharmacol Ther; 2013 Feb; 36(1):68-77. PubMed ID: 22489635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of cefotaxime during late pregnancy].
    Voigt R; Schröder S; Bierwisch I; Michels W
    Z Geburtshilfe Perinatol; 1989; 193(5):230-2. PubMed ID: 2683434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and clinical efficacy of cefotaxime for the treatment of septicaemia in dogs.
    Sumano H; Gutierrez L; Ocampo L
    Acta Vet Hung; 2004; 52(1):85-95. PubMed ID: 15119790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of pharmacokinetics of cefotaxime in uranyl nitrate-induced renal damage in black bengal goats.
    Dutta BP; Debnath SC; Mandal TK; Chakraborty AK
    J Vet Sci; 2004 Mar; 5(1):1-3. PubMed ID: 15028879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.